Picture of Caplin Point Laboratories logo

CAPLIPOINT — Caplin Point Laboratories News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: Caplin Point Laboratories Says Commencement Of Operations By Caplin One Labs

March 27 (Reuters) - Caplin Point Laboratories Ltd
 CAPL.NS :
    * COMMENCEMENT OF OPERATIONS BY CAPLIN ONE LABS
    * CAPLIN GROUP COMPLETES NEW ONCOLOGY (ANTI-CANCER) FACILITY
    * UNIT WILL FOCUS ON MANUFACTURING RANGE OF ORAL SOLID
DOSAGE
ONCOLOGY PRODUCTS
    * PLANS TO EXPAND PORTFOLIO TO OVER 50 ONCOLOGY PRODUCTS
PROGRESSIVELY
    * ONCOLOGY PRODUCTS WILL BE TARGETED AT LATIN AMERICAN
COUNTRIES
INITIALLY
    * IN MEDIUM TERM, TO LAUNCH PRODUCTS IN REGULATED MARKETS
SUCH AS
US, EU, MEXICO, OTHERS
    * INJECTABLE DIVISION TO COMMENCE OPERATIONS IN NEXT FEW
MONTHS

Source text for Eikon:  ID:nBSE4N2lKR 
Further company coverage:  CAPL.NS 

 ((reuters.briefs@thomsonreuters.com;))

Recent news on Caplin Point Laboratories

See all news